(Q81019308)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

5 January 2020

main subject

1 reference

1

Gratwohl A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Baldomero H

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Schmid O

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Horisberger B

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bargetzi M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Urbano-Ispizua A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

575-590

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16086045%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705104

5 January 2020

exact match

0 references

cites work

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Haemopoietic stem cells in the peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Cells Capable of Colony Formation in the Peripheral Blood of Man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukaemia in transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Umbilical cord blood transplantation--how, when and for whom?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Autologous peripheral blood stem cell transplantation for acute leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

The place of blood stem cells in allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Non-myeloablative stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Current indications for reduced-intensity allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021

Differences between graft product and donor side effects following bone marrow or stem cell donation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705104

7 January 2021